Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer

por Alvarado-Miranda, Alberto, Lara-Medina, Fernando Ulises, Muñoz-Montaño, Wendy R., Zinser-Sierra, Juan W., Galeana, Paula Anel Cabrera, Garza, Cynthia Villarreal, Sanchez Benitez, Daniel, Limón Rodríguez, Jesús Alberto, Arce Salinas, Claudia Haydee, Guijosa, Alberto, Arrieta, Oscar
Publicado 2023